The BSH Joint Venture (the Fund) was established in June 2001 and owns a pathology laboratory located in the Melbourne suburb of Heidelberg.
The Fund owns a property located at 16-18 Banksia Street, Heidelberg, a suburb of Melbourne. The property is fully leased to Dorevitch Pathology and is their central laboratory and administrative office for the Melbourne metropolitan area.
Founded in 1970, Dorevitch is a leading provider of pathology and medical diagnostic services to doctors, specialists and hospitals throughout Victoria as well as commercial and Government organisations in Australia and internationally. Dorevitch is the leading provider of pathology services in Victoria and the Property is the company’s main laboratory. Dorevitch is a wholly owned subsidiary of Primary Health Care Limited, an ASX 100 listed company.
Past performance is not an indicator of future performance. All information is at 31 December 2016 unless otherwise stated.
Net tangible asset value and distributions